InvestorsObserver – MINDCURE (MCURF) Releases First of its Kind Mental Health Digital Therapeutics Platform; Shares Decline

MINDCURE shares declined after releasing the MVP of digital therapeutic platform iSTRYM. Its features include treatment protocols, in-session tools, custom dashboards, integration tools and real-time patient assessment. iSTRYM was created to provide value for patients, therapists, and researchers alike. It will begin full commercial deployment in Q1 of 2022, with an initial focus on psychedelic clinics.

Access the article here.